• First Meeting of the Standing Committee to Advise the U.S. Department of State on Unexplained Health Effects on U.S. Government Employees and their Families at Overseas Embassies: Data Gathering Session Date: December 18, 2019 (10:30 AM Eastern)

    To facilitate the U.S. Department of State (DOS) in implementing one of its responsibilities to protect U.S. government employees and their family members overseas, the Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine will form a Standing Committee to Advise DOS on Unexplained Health Effects on U.S. Government Employees and their Families at Overseas Embassies. This standing committee will discuss best practices with DOS Bureau of Medical Services on topics including but not limited to health monitoring, medical interventions, risk assessment, and exposure mitigation for overseas locations that may present a higher risk of adverse health effects. The standing committee will evaluate current DOS practices for pre- and post-assignment health screening, provide expertise on potential epidemiologic studies, help with characterizing and understanding the current cases of potential acoustic trauma, and develop a better understanding of possible causes of these cases and approaches for future incidents whether of an apparent acoustic nature or a different environmental or clinical presentation. The standing committee will also keep DOS abreast of any emerging concerns, interventions, and protective measures as these come available. The standing committee will organize ongoing discussions, take on specific tasks and possibly issue classified and unclassified reports and recommendations on a variety of topics of importance to the DOS in regards to health effects from potential exposures overseas.
  • Examining the State of the Science of Mammalian Embryo Model Systems: A Workshop Date: January 17, 2020 (8:30 AM Eastern)
    Committee Only
    An ad hoc committee will plan and conduct a one day public workshop to explore the state of the science of mammalian embryo model systems, including nonhuman primate and human models. The goal of the workshop will be to begin with an overview of the developments and uses that have set the foundation for the field, then to focus in on opportunities and challenges for future work with embryo model systems.
  • An Examination of Emerging Bioethical Issues in Biomedical Research: A Workshop Date: February 26, 2020 (8:30 AM Eastern)

    A planning committee of the National Academies of Sciences, Engineering, and Medicine will be appointed to conduct a one day workshop to bring together stakeholders to discuss potential ethical issues that may arise from new and emerging trends in biomedical research (including behavioral and social research) and society. The workshop will identify a range of current and emerging bioethical issues - both in basic and clinical research - and explore a broad-range of stakeholder perspectives.
  • Advancing Progress in the Development and Implementation of Effective, High-Quality Cancer Screening: A Workshop Date: March 2, 2020 - March 3, 2020 (8:00 AM Eastern)

    Evidence-based screening approaches have contributed to improved patient outcomes, and research continues to develop and evaluate the potential of new strategies for early cancer detection.
  • The Role of Digital Health Technologies in Drug Development: A Workshop Date: March 24, 2020 (8:30 AM Eastern)

    As digital health technologies (e.g. smartphone apps, wearables, and mobile-device-based tools) – hardware and software – become increasingly available to consumers, providers, and researchers, there are new opportunities to address critical barriers or “pain points,” better connect patients and health care providers, and incorporate patient input throughout the drug research and development (R&D) life cycle. However, a lack of clarity when it comes to the evaluation, selection, and implementation of digital health technologies has impeded the practical application of these innovations. This workshop will provide a venue to discuss challenges and opportunities in digital health technologies for improving the probability of success in drug development and enabling precision medicine.